These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 34603013)
1. The Efficacy and Safety of Infliximab in Refractory Noninfectious Uveitis: A Meta-Analysis of Observational Studies. Xiong A; Liu D; Chen H; Yang G; Xiong C; Shuai Y; He L; Guo Z; Zhang L; Yang Y; Cui B; Shuai S Front Pharmacol; 2021; 12():620340. PubMed ID: 34603013 [No Abstract] [Full Text] [Related]
2. Efficacy and safety of adalimumab in the treatment of non-infectious uveitis: a meta-analysis and systematic review. Ming S; Xie K; He H; Li Y; Lei B Drug Des Devel Ther; 2018; 12():2005-2016. PubMed ID: 30013320 [TBL] [Abstract][Full Text] [Related]
3. Outcomes of treatment with sirolimus for non-infectious uveitis: a meta-analysis and systematic review. Cabahug VLO; Uy HS; Yu-Keh E; Sapno KJD Clin Ophthalmol; 2019; 13():649-669. PubMed ID: 31114144 [TBL] [Abstract][Full Text] [Related]
4. Infliximab Versus Adalimumab in the Treatment of Refractory Inflammatory Uveitis: A Multicenter Study From the French Uveitis Network. Vallet H; Seve P; Biard L; Baptiste Fraison J; Bielefeld P; Perard L; Bienvenu B; Abad S; Rigolet A; Deroux A; Sene D; Perlat A; Marie I; Feurer E; Hachulla E; Fain O; Clavel G; Riviere S; Bouche PA; Gueudry J; Pugnet G; Le Hoang P; Resche Rigon M; Cacoub P; Bodaghi B; Saadoun D; Arthritis Rheumatol; 2016 Jun; 68(6):1522-30. PubMed ID: 27015607 [TBL] [Abstract][Full Text] [Related]
5. Retrospective case review of pediatric patients with uveitis treated with infliximab. Rajaraman RT; Kimura Y; Li S; Haines K; Chu DS Ophthalmology; 2006 Feb; 113(2):308-14. PubMed ID: 16406545 [TBL] [Abstract][Full Text] [Related]
6. Long-Term Outcomes of Treatment with Biological Agents in Eyes with Refractory, Active, Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis. Al-Janabi A; El Nokrashy A; Sharief L; Nagendran V; Lightman S; Tomkins-Netzer O Ophthalmology; 2020 Mar; 127(3):410-416. PubMed ID: 31607412 [TBL] [Abstract][Full Text] [Related]
7. A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes. Suhler EB; Smith JR; Wertheim MS; Lauer AK; Kurz DE; Pickard TD; Rosenbaum JT Arch Ophthalmol; 2005 Jul; 123(7):903-12. PubMed ID: 16009830 [TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritis. Murphy CC; Ayliffe WH; Booth A; Makanjuola D; Andrews PA; Jayne D Ophthalmology; 2004 Feb; 111(2):352-6. PubMed ID: 15019389 [TBL] [Abstract][Full Text] [Related]
9. Effectiveness and Safety of Anti-Tumor Necrosis Factor-Alpha Agents Treatment in Behcets' Disease-Associated Uveitis: A Systematic Review and Meta-Analysis. Hu Y; Huang Z; Yang S; Chen X; Su W; Liang D Front Pharmacol; 2020; 11():941. PubMed ID: 32670062 [TBL] [Abstract][Full Text] [Related]
10. Infliximab for the treatment of refractory noninfectious Uveitis: a study of 88 patients with long-term follow-up. Kruh JN; Yang P; Suelves AM; Foster CS Ophthalmology; 2014 Jan; 121(1):358-364. PubMed ID: 24011995 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of Adalimumab in Noninfectious Uveitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Li B; Li H; Zhang L; Zheng Y Front Pharmacol; 2021; 12():673984. PubMed ID: 33981245 [No Abstract] [Full Text] [Related]
12. Efficacy and Safety of Anti-TNFα Therapy for Uveitis Associated with Juvenile Idiopathic Arthritis: A Systematic Review and Meta-Analysis. Li Y; Mao X; Tang X; Mao H Rheumatol Ther; 2021 Jun; 8(2):711-727. PubMed ID: 33721267 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness of infliximab, adalimumab and golimumab for non-infectious refractory uveitis in adults. Borrás-Blasco J; Casterá DE; Cortes X; Abad FJ; Rosique-Robles JD; Mallench LG Int J Clin Pharmacol Ther; 2015 May; 53(5):377-90. PubMed ID: 25345430 [TBL] [Abstract][Full Text] [Related]
14. TNF inhibition for ophthalmic indications: current status and outlook. Rifkin LM; Birnbaum AD; Goldstein DA BioDrugs; 2013 Aug; 27(4):347-57. PubMed ID: 23568177 [TBL] [Abstract][Full Text] [Related]
15. Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT. Ramanan AV; Dick AD; Jones AP; Hughes DA; McKay A; Rosala-Hallas A; Williamson PR; Hardwick B; Hickey H; Rainford N; Hickey G; Kolamunnage-Dona R; Culeddu G; Plumpton C; Wood E; Compeyrot-Lacassagne S; Woo P; Edelsten C; Beresford MW Health Technol Assess; 2019 Apr; 23(15):1-140. PubMed ID: 31033434 [TBL] [Abstract][Full Text] [Related]